Cascadian Therapeutics Inc (USA) Stock

Stocks

04/01/18	Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	GL
02/01/18	Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	GL
13/12/17	Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	GL
08/12/17	Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	GL
09/11/17	Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	GL

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CASCADIAN THERAPEUTICS INC (USA)	-.--%	+0.50%	-	-	0
ARGENX SE	+0.22%	+5.00%	+78.89%	+135.72%	58.73B
WUXI APPTEC CO., LTD.	+2.32%	+5.89%	+76.81%	+99.20%	53.92B
BIONTECH SE	-10.61%	+8.38%	-9.90%	-9.62%	24.67B
INSMED INCORPORATED	-0.30%	+6.82%	+13.60%	+428.91%	24.19B
WUXI BIOLOGICS (CAYMAN) INC.	+4.74%	+13.47%	+46.43%	+0.03%	18.8B
GENMAB A/S	-0.29%	+9.58%	+44.35%	-28.08%	17.61B
PHARMAESSENTIA CORPORATION	0.00%	+16.74%	+171.12%	+355.99%	16.25B
EXELIXIS, INC.	+3.50%	+4.92%	+26.07%	+192.26%	14.04B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.72%	+20.94%	+51.67%	-	13.9B
Average	+2.46%	+8.08%	+55.45%	+146.80%	26.9B
Weighted average by Cap.	+2.20%	+6.00%	+59.39%	+137.80%

Employees

Sector